|
Biotech 2009 will include tracks on topics relevant to the Mid-Atlantic region's bioscience industry. They include:
Monday, November 16, 2009
Drug Delivery, Device, and Diagnostics
- The Evolving Role of Diagnostics in Bioscience Technology and Health Care
- New Trends in Drug Delivery of Biotechnology-Derived Therapeutics
- Advancements for the Diagnosis and Treatment of Neurological Disorders
Growth Strategies for Bioscience Companies
- Virtues and Vices of Being Virtual
- Creative Partnering: How to Thrive in the "New Normal"
- Developing Value for Your Exit Strategy
Regulatory
- Biosimilars - Challenges and Opportunities
- The FDA Amendments Act of 2007 - What You Need to Know About the Ongoing Implementation
- FDA and Industry Interactions in the Face of a Developing Pandemic
Tuesday, November 17, 2009
Communications
- Trends and Tactics: How Bioscience Companies are Harnessing Social Media to Reach Key Audiences
- Creating and Delivering the Message: Advanced Lessons in Reputation Management
- Communicating Value During Times of Uncertainty: What to Do When No One Is Listening
Finance
- Navigating the Capital Markets Including Biotech IPO Opportunities: When Will the Window Open?
- Extending the Runway - Strategies to Preserve Cash and Obtain Non-Dilutive Financing
- Creative Financing Transactions - The Emergence of Financing Partners from Collaborative Relationships Including Structured Deals
Hot Topics in Business
- Redefined Role of Venture Capitalists: Matching Management with Products
- Impact of Health Care Reform on Biotech, Medical Device, and Pharmaceutical Companies
- Building Value in a Development-Stage Biotech Company
Hot Topics in Science
- Immunotherapeutics: Harnessing Innate Immunity for the Treatment of Infectious, Inflammatory, and Autoimmune Diseases
- Regenerative Medicine for Brain Injury: From the Battlefield to the Clinic
- New Frontiers: Mitochondrial Dysfunction, Dysregulation, and Modulation
|
